J&J To Pay $400M Over Criminal Charge In Risperdal Case
A Pennsylvania federal judge on Thursday approved a $400 million criminal penalty against Johnson & Johnson unit Janssen Pharmaceuticals Inc., part of a larger $2.2 billion settlement announced Monday, after the...To view the full article, register now.
Already a subscriber? Click here to view full article